Frontiers
US$ 22.01
what does igf-1 lr3 1mg LONG® R³ IGF-I
Description
10.1038/224117a0 Nature
PLoS ONE 7:e39953 10.1371/journal.pone.0039953 [DOI] [PMC free article] [PubMed] [Google Scholar] Blandini F., Nappi G., Greenamyre J
This analgesic self-synergy is significantly attenuated by the administration of naloxone, an opioid receptor antagonist, at the spinal level (Raffa et al., 2000)
Johar SS, Talbert JN
Dana Parish: I agree
Zo Deag for her technical support for the SUET data
